Search filters

List of works by Paolo Lunghi

Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity

scientific article published on 01 April 1997

Air purification and indoor biologic pollutants

scientific article published on 01 August 2000

Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.

scientific article

Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.

scientific article published on December 2006

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.

scientific article published on 13 March 2008

Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: Synthesis, spectroscopic properties and biological activity ⬇️

scientific article published on March 1, 1998

Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts

scientific article published on 01 September 2003

Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis.

scientific article published on March 2004

Early Proinflammatory Activation of Renal Tubular Cells by Normal and Pathologic IgG

scientific article published on 18 March 2005

Emerging MEK inhibitors.

scientific article published on June 2010

Emerging Raf inhibitors.

scientific article published on December 2009

Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients

scientific article published on 6 October 2005

MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors

scientific article published on 01 January 2002

MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis.

scientific article published on 7 February 2006

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis

scientific article published on 13 March 2003

Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes.

scientific article

Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones.

scientific article published on January 2000

Synthesis, structure, and spectroscopic properties of acetato(dimethyl)(pyridine-2-carbaldehydethiosemicarbazonato)tin(IV) acetic acid solvate, [SnMe2(PyTSC)(OAc)].HOAc. Comparison of its biological activity with that of some structurally related di

scientific article published on 01 April 1996

Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands

scientific article published on 01 September 1999

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.

scientific article published on 26 June 2008

Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.

scientific article published on 13 March 2008

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angio

scientific article published on 11 September 2007

The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting.

scientific article published on 27 October 2009

Transition-metal complexes of isatin-beta-thiosemicarbazone. X-ray crystal structure of two nickel complexes

scientific article published on 01 January 1999

Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.

scientific article

p73 and p53 pathway in human breast cancers

scientific article published on 01 April 2007

Paulina is supported by:

About Paulina

Help